WallStreetZenWallStreetZen

NASDAQ: IOSP
Innospec Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Innospec earnings were $19.3M for the trailing 12 months ending Jun 30, 2025, with -87.2% growth year over year. The latest IOSP earnings report on Jun 30, 2025 announced Q2 2025 earnings of $23.5M, down 28.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IOSP reported annual earnings of $35.6M, with -74.4% growth. The next IOSP earnings date is Nov 4, 2025.

IOSP past earnings growth

How has IOSP's earnings growth performed historically?

Company
-87.19%
Industry
6.09%
Market
34.44%
IOSP's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
IOSP's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
IOSP's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

IOSP earnings history

Current Revenue
$1.8B
Current Earnings
$19.3M
Current Profit Margin
1.1%
IOSP's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

IOSP Return on Equity

Current Company
1.5%
Current Industry
19.6%
Current Market
30.7%
IOSP's Return on Equity (1.5%)... subscribe to Premium to read more.
High Return on Equity Performance

IOSP undefined

Current Company
1.1%
Current Industry
6.5%
IOSP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IOSP announces earnings.

IOSP undefined

Current Company
0.63%
Current Industry
11.5%
IOSP's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IOSP vs Specialty Chemical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IOSP$53.20M$19.30M-19.16%$0.77
MTX$161.10M$2.10M-52.95%$0.08
NGVT-$35.10M-$216.60MN/A-$5.95
ASH-$657.00M-$860.00MN/A-$18.70
KWR$155.06M-$7.13MN/A-$0.44
View Top Specialty Chemical Stocks

IOSP earnings dates

Next earnings date
Nov 4, 2025

Innospec Earnings Reports & History FAQ

What were Innospec's earnings last quarter?

On IOSP's earnings call on Invalid Date, Innospec (NASDAQ: IOSP) reported Q2 2025 earnings per share (EPS) of $0.94, up 24.8% year over year. Total IOSP earnings for the quarter were $23.50 million. In the same quarter last year, Innospec's earnings per share (EPS) was $1.25.

If you're new to stock investing, here's how to buy Innospec stock.

When does Innospec report earnings?

The next IOSP earnings call is Invalid Date. Add IOSP to your watchlist to be reminded of Innospec's next earnings date.

Is Innospec profitable or losing money?

As of the last Innospec earnings report, Innospec is currently profitable. Innospec's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $19.30 million, a 87.1% decrease year over year.

What was IOSP's earnings growth in the past year?

As of Innospec's earnings date in Invalid Date, Innospec's earnings has grown -87.19% year over year. This is 93.28 percentage points lower than the US Specialty Chemicals industry earnings growth rate of 6.09%. IOSP earnings in the past year totalled $19.30 million.

What are Innospec's earnings expectations?

The current EPS estimate for Innospec's earnings report in Invalid Date is $1.12.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.